Involvement of CYP1A2 in mexiletine metabolism.

AIMS Mexiletine has been reported to be hydroxylated by cytochrome P450 2D6 (CYP2D6) in humans. However, the involvement of CYP1A2 in the metabolism of mexiletine has been proposed based on the interaction with theophylline which is mainly metabolized by CYP1A2. The aim of this study was to clarify the role of human CYP1A2 in mexiletine metabolism. METHODS Human CYP isoforms involved in mexiletine metabolism were investigated using microsomes from human liver and B-lymphoblastoid cells expressing human CYPs. The contributions of CYP1A2 and CYP2D6 to mexiletine metabolism were estimated by the relative activity factor (RAF). RESULTS Mexiletine p- and 2-hydroxylase activities in human liver microsomes were inhibited by ethoxyresorufin and furafylline as well as quinidine. Mexiletine p- and 2-hydroxylase activities in microsomes from nine human livers correlated significantly with bufuralol 1'-hydroxylase activity (r = 0.907, P < 0.001 and r = 0.886, P < 0.01, respectively). Microsomes of B-lymphoblastoid cells expressing human CYP1A2 exhibited lower mexiletine p- and 2-hydroxylase activities than those expressing human CYP2D6. It was estimated by RAF that the major isoform involved in mexiletine metabolism was CYP2D6, and the contribution of CYPIA2 to both mexiletine p- and 2-hydroxylase activities was 7-30% in human liver microsomes. However, the Km values of the expressed CYP1A2 (approximately 15 microM) were almost identical with those of the expressed CYP2D6 (approximately 22 microM) and human liver microsomes. CONCLUSIONS Mexiletine is a substrate of CYP1A2. The data obtained in this study suggest that the interaction of mexiletine with theophylline might be due to competitive inhibition of CYP1A2.

[1]  R. Tukey,et al.  Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. , 1990, Cancer research.

[2]  T. Kamataki,et al.  Effects of lyophilization and storage of rat liver microsomes on activity of aniline hydroxylase, contents of cytochrome b5 and cytochrome p-450 and aniline-induced p-450 difference spectrum. , 1974, Japanese journal of pharmacology.

[3]  J. Turgeon,et al.  Effect of cigarette smoking on mexiletine kinetics , 1985, Clinical pharmacology and therapeutics.

[4]  S. Clarke,et al.  Characterization of the inhibition of P4501A2 by furafylline. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  F. Gonzalez,et al.  Development of a human lymphoblastoid cell line constitutively expressing human CYP1A1 cDNA: substrate specificity with model substrates and promutagens. , 1994, Carcinogenesis.

[6]  A. Gillis,et al.  Clinical Pharmacokinetics of the Newer Antiarrhythmic Agents , 1984, Clinical pharmacokinetics.

[7]  J. Miners,et al.  Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies. , 1988, Biochemical pharmacology.

[8]  R. Shanks,et al.  The clinical pharmacology of mexiletine. , 1978, British journal of clinical pharmacology.

[9]  J. Clements,et al.  Absorption, distribution and elimination of mexiletine. , 1977, Postgraduate medical journal.

[10]  M. Rawlins,et al.  Ethoxyresorufin O-deethylation by human liver microsomes. , 1986, British journal of clinical pharmacology.

[11]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[12]  J. Depierre,et al.  Measurement of cytochrome P-450 in the presence of large amounts of contaminating hemoglobin and methemoglobin. , 1978, Analytical biochemistry.

[13]  C. Libersa,et al.  The metabolism of mexiletine in relation to the debrisoquine/sparteine-type polymorphism of drug oxidation. , 1991, British journal of clinical pharmacology.

[14]  D. Roden,et al.  Pharmacology, electrophysiology, and pharmacokinetics of mexiletine. , 1984, American heart journal.

[15]  P. Guzelian,et al.  Characterization of human liver cytochromes P-450 involved in theophylline metabolism. , 1992, Drug metabolism and disposition: the biological fate of chemicals.

[16]  H. Yamazaki,et al.  Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. , 1994, The Journal of pharmacology and experimental therapeutics.

[17]  H K Kroemer,et al.  Influence of debrisoquine phenotype and of quinidine on mexiletine disposition in man. , 1991, The Journal of pharmacology and experimental therapeutics.

[18]  H. Yamazaki,et al.  Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. , 1994, Molecular pharmacology.

[19]  P. Bechtel,et al.  Effect of quinidine on the dextromethorphan O-demethylase activity of microsomal fractions from human liver. , 1989, British journal of clinical pharmacology.

[20]  J. Miners,et al.  Characterisation of theophylline metabolism in human liver microsomes. , 1987, British journal of clinical pharmacology.

[21]  K. Chiba,et al.  Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2. , 1998, British journal of clinical pharmacology.

[22]  R. Edwards,et al.  A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. , 1988, British journal of clinical pharmacology.

[23]  J. Vacek,et al.  Mexiletine effects on theophylline disposition , 1991, Clinical pharmacology and therapeutics.

[24]  C. Libersa,et al.  Mexiletine metabolism in vitro by human liver. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[25]  C. Crespi.  Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research , 1995 .

[26]  T. Kronbach,et al.  High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. , 1987, Analytical biochemistry.

[27]  A. Freiburghaus,et al.  Metabolism of theophylline by cDNA-expressed human cytochromes P-450. , 1995, British journal of clinical pharmacology.

[28]  Kaoru Kobayashi,et al.  Identification of cytochrome P450 isoforms involved in citalopram N-demethylation by human liver microsomes. , 1997, The Journal of pharmacology and experimental therapeutics.

[29]  P. Darnerud,et al.  Induction of 7-ethoxyresorufin-O-deethylase (EROD) activity in mice foetuses by the PCB-congener 3,3',4,4'-tetrachlorobiphenyl. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.

[30]  Beckett Ah,et al.  The distribution, metabolism and excretion of mexiletine in man. , 1977 .

[31]  C. Sengstag,et al.  Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae. , 1992, Drug metabolism and disposition: the biological fate of chemicals.